tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate oxalate(2:1)

Catalog No. :
ACKGXE680
CAS No. :
1788054-74-9
Molecular Formula :
C24H42N4O8
Molecular Weight :
514.62

IUPAC Name:tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate

tert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate oxalate(2:1) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$82.00Login to see priceIn stockInquiry
250mg98%$130.00Login to see priceIn stockInquiry
1g98%$332.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate oxalate(2:1)
IUPAC Nametert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate
MDL No.MFCD29037484
Molecular FormulaC24H42N4O8
Molecular Weight514.62
SMILESO=C(N1CCC12CNCC2)OC(C)(C)C.O=C(N3CCC34CNCC4)OC(C)(C)C.O=C(O)C(O)=O
InChI KeyDNHJCRBVFAVRNN-UHFFFAOYSA-N
Synonymtert-Butyl 1,6-diazaspiro[3.4]octane-1-carboxylate oxalate(2:1);1,6-Diazaspiro[3.4]octane-1-carboxylic acid, 1,1-dimethylethyl ester, ethanedioate (2:1);1-Boc-1,6-diazaspiro[3.4]octane Hemioxalate;tert-butyl 1,6-diazaspiro[3.4]octane-1-carboxylate hemioxalate - [D30153]
CAS No.1788054-74-9
PubChem CID91933830

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACKGXE680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGXE680 route product structure diagram
    ACKGXE6801788054-74-9 In Stock
Inquiry

2. ACKGXE680 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACKGXE680 route product structure diagram
    ACKGXE6801788054-74-9 In Stock
Inquiry

Comments (0)